With the acquisition of the Swedish company Key2Compliance AB (Key2Compliance), GBA Group is expanding its range of consulting and training services for the medical device, In Vitro Diagnostics (IVD), and pharmaceutical industry. GBA Group is thus taking another important step towards establishing itself as a broad service provider for international customers in this area.
Key2Compliance was founded in Stockholm, Sweden in 1994 and is one of the fastest-growing consultancy and training service provider for medical devices, IVD, and pharmaceuticals companies in the Scandinavian market. Key areas of expertise at Key2Compliance include Quality Assurance, Regulatory Affairs, Clinical Development (CRO), Biological Safety, as well as Training and Courses. Today, the company employs more than 70 experts and, in addition to its headquarters in Stockholm, has two other branches in Sweden and one in Copenhagen, Denmark.
Steffen Walter, CEO GBA Group explains, “As we have set ourselves the goal of being a broad-based service provider for medical devices, Key2Compliance, with its consulting and training services and expertise, is a perfect fit for GBA Group. The expansion of our service portfolio enables us to provide our customers with optimal support along the value chain, from preclinical development and the conduct of clinical trials through to production release and quality assurance”.
Jan Hellqvist, CEO Key2Compliance says, “With GBA Group, its structure and management we found the right partner to foster our ongoing journey of growth and internationalization. The company's culture of entrepreneurship, local autonomy, and genuine support as well as the broad variety of revealing synergies between both companies’ services convinced me. Therefore, I believe that this step will significantly boost Key2Compliance and GBA Group, and I‘m eagerly anticipating the years to come.”
Key2Compliance was founded in Stockholm, Sweden in 1994 and is one of the fastest-growing consultancy and training service provider for medical devices, IVD, and pharmaceuticals companies in the Scandinavian market. Key areas of expertise at Key2Compliance include Quality Assurance, Regulatory Affairs, Clinical Development (CRO), Biological Safety, as well as Training and Courses. Today, the company employs more than 70 experts and, in addition to its headquarters in Stockholm, has two other branches in Sweden and one in Copenhagen, Denmark.
Steffen Walter, CEO GBA Group explains, “As we have set ourselves the goal of being a broad-based service provider for medical devices, Key2Compliance, with its consulting and training services and expertise, is a perfect fit for GBA Group. The expansion of our service portfolio enables us to provide our customers with optimal support along the value chain, from preclinical development and the conduct of clinical trials through to production release and quality assurance”.
Jan Hellqvist, CEO Key2Compliance says, “With GBA Group, its structure and management we found the right partner to foster our ongoing journey of growth and internationalization. The company's culture of entrepreneurship, local autonomy, and genuine support as well as the broad variety of revealing synergies between both companies’ services convinced me. Therefore, I believe that this step will significantly boost Key2Compliance and GBA Group, and I‘m eagerly anticipating the years to come.”
